Insider Trading Alert - LNG, NSR, FCN And OPK Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Dec. 18, 2013, 124 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $1,000.00 to $864,567,000.00.

Highlighted Stocks Traded by Insiders:

Cheniere Energy (LNG) - FREE Research Report

Teague R Keith who is Sr. VP - Asset Group at Cheniere Energy sold 20,000 shares at $41.08 on Dec. 18, 2013. Following this transaction, the Sr. VP - Asset Group owned 1.1 million shares meaning that the stake was reduced by 1.78% with the 20,000-share transaction.

Rayford Greg W. who is Sr. VP and General Counsel at Cheniere Energy sold 6,500 shares at $40.96 on Dec. 18, 2013. Following this transaction, the Sr. VP and General Counsel owned 989,390 shares meaning that the stake was reduced by 0.65% with the 6,500-share transaction.

The shares most recently traded at $41.03, up $0.07, or 0.17% since the insider transaction. Historical insider transactions for Cheniere Energy go as follows:

  • 4-Week # shares sold: 40,000
  • 12-Week # shares sold: 213,000
  • 24-Week # shares sold: 432,500

The average volume for Cheniere Energy has been 3.6 million shares per day over the past 30 days. Cheniere Energy has a market cap of $9.9 billion and is part of the basic materials sector and energy industry. Shares are up 119.97% year-to-date as of the close of trading on Wednesday.

Cheniere Energy, Inc., an energy company, engages in the liquefied natural gas (LNG) related business. It operates through two segments, LNG Terminal Business, and LNG and Natural Gas Marketing Business. Currently there are 4 analysts that rate Cheniere Energy a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LNG - FREE

TheStreet Quant Ratings rates Cheniere Energy as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and growth in earnings per share. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and generally higher debt management risk. Get the full Cheniere Energy Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

NeuStar (NSR) - FREE Research Report

Berry Alex who is SVP, Sales at NeuStar sold 953 shares at $49.03 on Dec. 18, 2013. Following this transaction, the SVP, Sales owned 25,916 shares meaning that the stake was reduced by 3.55% with the 953-share transaction.

The shares most recently traded at $48.72, down $0.31, or 0.64% since the insider transaction. Historical insider transactions for NeuStar go as follows:

  • 12-Week # shares sold: 2,423
  • 24-Week # shares sold: 2,423

The average volume for NeuStar has been 580,500 shares per day over the past 30 days. NeuStar has a market cap of $3.0 billion and is part of the technology sector and telecommunications industry. Shares are up 15.96% year-to-date as of the close of trading on Wednesday.

NeuStar, Inc. provides technology and directory services to customers pursuant to various private commercial and government contracts worldwide. The company operates in three segments: Carrier Services, Enterprise Services, and Information Services. The company has a P/E ratio of 27.6. Currently there are 2 analysts that rate NeuStar a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NSR - FREE

TheStreet Quant Ratings rates NeuStar as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, reasonable valuation levels, good cash flow from operations and increase in stock price during the past year. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full NeuStar Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

FTI Consulting (FCN) - FREE Research Report

Dunn Jack B Iv who is President & CEO at FTI Consulting sold 115,594 shares at $40.91 on Dec. 18, 2013. Following this transaction, the President & CEO owned 185,257 shares meaning that the stake was reduced by 38.42% with the 115,594-share transaction.

Bannister David G who is EVP & Regional Chairman at FTI Consulting sold 30,638 shares at $42.15 on Dec. 18, 2013. Following this transaction, the EVP & Regional Chairman owned 98,626 shares meaning that the stake was reduced by 23.7% with the 30,638-share transaction.

The shares most recently traded at $41.35, down $0.80, or 1.93% since the insider transaction.

The average volume for FTI Consulting has been 311,900 shares per day over the past 30 days. FTI Consulting has a market cap of $1.7 billion and is part of the services sector and diversified services industry. Shares are up 25.3% year-to-date as of the close of trading on Wednesday.

FTI Consulting, Inc., together with its subsidiaries, operates as a business advisory firm enabling organizations to protect enterprise values in complex economic, legal, and regulatory, environments worldwide. Currently there are 2 analysts that rate FTI Consulting a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on FCN - FREE

TheStreet Quant Ratings rates FTI Consulting as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and feeble growth in the company's earnings per share. Get the full FTI Consulting Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Opko Health (OPK) - FREE Research Report

Frost Phillip Md Et Al who is CEO & Chairman at Opko Health bought 56,800 shares at $8.46 on Dec. 18, 2013. Following this transaction, the CEO & Chairman owned 137.5 million shares meaning that the stake was reduced by 0.04% with the 56,800-share transaction.

The shares most recently traded at $8.84, up $0.38, or 4.29% since the insider transaction.

The average volume for Opko Health has been 5.5 million shares per day over the past 30 days. Opko Health has a market cap of $3.4 billion and is part of the health care sector and health services industry. Shares are up 84.2% year-to-date as of the close of trading on Wednesday.

Opko Health, Inc., a pharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies. It operates in two segments, Pharmaceuticals and Diagnostics. Currently there are 3 analysts that rate Opko Health a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OPK - FREE

TheStreet Quant Ratings rates Opko Health as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and weak operating cash flow. Get the full Opko Health Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Three Big Factors That Rocked the Stock Market Tuesday

Three Big Factors That Rocked the Stock Market Tuesday

Dow Tumbles Over 400 Points; S&P 500 and Nasdaq Also Finish Lower

Dow Tumbles Over 400 Points; S&P 500 and Nasdaq Also Finish Lower

Caterpillar Bulldozes Industrial Sector With Bad News on Earnings Call

Caterpillar Bulldozes Industrial Sector With Bad News on Earnings Call

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash

Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug

Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug